Bayforest Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Sell
6,231
-2,219
-26% -$50.8K 0.12% 340
2026
Q1
$186K Sell
8,450
-13,443
-61% -$234K 0.21% 144
2025
Q4
$258K Buy
21,893
+6,853
+46% +$88K 0.19% 196
2025
Q3
$238K Buy
+15,040
New +$218K 0.11% 340

Other funds holding CC

Bayforest Capital's CC Position: Q2 2026 in Review

Bayforest Capital reduced its Chemours (CC) stake by 26% in Q2 2026, selling an estimated $50.8K and leaving 6,231 shares worth $128K. The position accounts for 0.12% of the portfolio, ranked #340.

Bayforest Capital first reported a position in CC in Q3 2025 and has held it in 4 quarters since. The position peaked at $258K in Q4 2025. 473 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Bayforest Capital held 6,231 shares of Chemours worth $128K as of Q2 2026.
  • Bayforest Capital sold 2,219 Chemours shares in Q2 2026, an estimated $50.8K.
  • Chemours made up 0.12% of Bayforest Capital's portfolio in Q2 2026, its #340 holding.
  • Bayforest Capital first reported a position in Chemours in Q3 2025 and has held it in 4 quarters since.
  • Bayforest Capital's Chemours position peaked at $258K in Q4 2025.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.